title: PKC activators enhance GABAergic neurotransmission and paired-pulse facilitation in hippocampal CA1 pyramidal neurons.
abstract: Bryostatin-1, a potent agonist of protein kinase C (PKC), has recently been found to enhance spatial learning and long-term memory in rats, mice, rabbits and the nudibranch Hermissenda, and to exert profound neuroprotective effects on Alzheimer's disease (AD) in transgenic mice. However, details of the mechanistic effects of bryostatin on learning and memory remain unclear. To address this issue, whole-cell recording, a dual-recording approach and extracellular recording techniques were performed on young (2-4months) Brown-Norway rats. We found that bath-applied bryostatin-1 significantly increased the frequency and amplitude of spontaneous inhibitory postsynaptic currents (sIPSCs). The firing rate of GABAergic interneurons significantly was also increased as recorded with a loosely-attached extracellular recording configuration. Simultaneous recordings from communicating cell pairs of interneuron and pyramidal neuron revealed unique activity-dependent properties of GABAergic synapses. Furthermore, the bryostatin-induced increase of the frequency and amplitude of IPSCs was blocked by methionine enkephalin which selectively suppressed the excitability of interneurons. Pretreatment with RO-32-0432, a relatively specific PKCα antagonist, blocked the effect of bryostatin on sIPSCs. Finally, bryostatin increased paired-pulse ratio of GABAergic synapses that lasted for at least 20min while pretreatment with RO-32-0432 significantly reduced the ratio. In addition, 8-[2-(2-pentyl-cyclopropylmethl)-cyclopropyl]-octanoic acid (DCP-LA), a selective PKCε activator, also increased the frequency and amplitude of sIPSCs. Taken together, these results suggest that bryostatin enhances GABAergic neurotransmission in pyramidal neurons by activating the PKCα & ε-dependent pathway and by a presynaptic mechanism with excitation of GABAergic interneurons. These effects of bryostatin on GABAergic transmissions and modifiability may contribute to the improvement of learning and memory previously observed to be induced by bryostatin.
authors.affiliation: Blanchette Rockefeller Neurosciences Institute, Morgantown, WV 26506, United States of America. Electronic address: changqingxu@hotmail.com.
authors.forename: C
authors.initials: C
authors.lastname: Xu
authors.affiliation: Blanchette Rockefeller Neurosciences Institute, Morgantown, WV 26506, United States of America.
authors.forename: Q-Y
authors.initials: QY
authors.lastname: Liu
authors.affiliation: Blanchette Rockefeller Neurosciences Institute, Morgantown, WV 26506, United States of America.
authors.forename: D L
authors.initials: DL
authors.lastname: Alkon
mesh_terms: D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D054713:Bryostatins / Q000494:pharmacology*; D056547:CA1 Region, Hippocampal / Q000187:drug effects* / Q000502:physiology; D002210:Caprylates / Q000494:pharmacology; D004744:Enkephalin, Methionine / Q000494:pharmacology; D020536:Enzyme Activators / Q000494:pharmacology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D007211:Indoles / Q000494:pharmacology; D053444:Inhibitory Postsynaptic Potentials / Q000187:drug effects; D007395:Interneurons / Q000187:drug effects / Q000502:physiology; D008297:Male; D018782:Maze Learning / Q000187:drug effects; D018377:Neurotransmitter Agents / Q000494:pharmacology; D018408:Patch-Clamp Techniques; D017729:Presynaptic Terminals / Q000187:drug effects / Q000502:physiology; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000378:metabolism; D017966:Pyramidal Cells / Q000187:drug effects* / Q000502:physiology; D011758:Pyrroles / Q000494:pharmacology; D051381:Rats; D013569:Synapses / Q000187:drug effects / Q000502:physiology; D009435:Synaptic Transmission / Q000187:drug effects* / Q000502:physiology; D005680:gamma-Aminobutyric Acid / Q000378:metabolism*
chemical_list: C506022:8-(2-(2-pentyl-cyclopropylmethyl)cyclopropyl)octanoic acid; D054713:Bryostatins; D002210:Caprylates; D020536:Enzyme Activators; D004791:Enzyme Inhibitors; D007211:Indoles; D018377:Neurotransmitter Agents; D011758:Pyrroles; C085989:Ro 32-0432; C046785:bryostatin 1; D005680:gamma-Aminobutyric Acid; D004744:Enkephalin, Methionine; D011493:Protein Kinase C
keywords: GABA; PKCα; PKCε; bryostatin; synaptic plasiticity